Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-κB ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity of osteoclasts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback